Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic neoplasms | D011471 | — | C61 | — | 3 | — | — | — | 3 |
Lung neoplasms | D008175 | — | C34.90 | 1 | 1 | — | — | — | 2 |
Lymphoma | D008223 | — | C85.9 | — | 2 | — | — | — | 2 |
Neuroendocrine carcinoma | D018278 | — | — | — | 1 | — | — | — | 1 |
Aggression | D000374 | EFO_0003015 | — | — | 1 | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | — | 1 | — | — | — | 1 |
Malignant mesothelioma | D000086002 | — | — | — | 1 | — | — | — | 1 |
Mesothelioma | D008654 | — | C45 | — | 1 | — | — | — | 1 |
Hodgkin disease | D006689 | — | C81 | — | 1 | — | — | — | 1 |
T-cell lymphoma | D016399 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Renal cell carcinoma | D002292 | EFO_0000376 | — | 1 | — | — | — | — | 1 |
Carcinoma | D002277 | — | C80.0 | 1 | — | — | — | — | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | — | — | — | — | 1 |
Melanoma | D008545 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Molgramostim |
INN | molgramostim |
Description | Molgramostim is a recombinant granulocyte macrophage colony-stimulating factor which functions as an immunostimulator.
|
Classification | Protein |
Drug class | colony-stimulating factors: granulocyte macrophage colony-stimulating factors (GM-CSF); colony-stimulating factors: macrophage colony-stimulating factors (M-CSF) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2109134 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | B321AL142J (ChemIDplus, GSRS) |